A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

St Vincents Hospital Melbourne, Fitzroy

Royal Perth Hospital, Perth

Mount Sinai Medical Center, New York

Memorial Sloan Kettering Cancer Center, New York

Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center, Winston-Salem

Hosp Univ Fund Jimenez Diaz, Madrid

UNIV. HOSP. October 12, Madrid

Atrium Health, Charlotte

Emory University, Atlanta

Clinica Univ. de Navarra, Pamplona

University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham

Hosp Clinico Univ de Salamanca, Salamanca

Hosp. Univ. Marques de Valdecilla, Santander

Cleveland Clinic, Cleveland

Sheba Medical Center, Ramat Gan

Mayo Clinic, Rochester

Washington University St. Louis School Medicine Siteman Cancer Center, St Louis

Tel Aviv Sourasky Medical Center, Tel Aviv

University of Arkansas for Medical Sciences, Little Rock

The University of Texas MD Anderson Cancer Center, Houston

Colorado Blood Cancer Institute, Denver

Hadassah Medical Center, Jerusalem

Oregon Health And Science University, Portland

Arthur J E Child Comprehensive Cancer Centre, Calgary

Alberta Health Services, Edmonton

Princess Margaret Cancer Centre University Health Network, Toronto

McGill University Health Centre, Montreal

Kanazawa University Hospital, Kanazawa

Nagoya City University Hospital, Nagoya

Osaka University Hospital, Osaka

Tohoku University Hospital, Sendai

Japanese Red Cross Medical Center, Shibuya City

Seoul National University Hospital, Seoul

Severance Hospital Yonsei University Health System, Seoul

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

The Catholic University of Korea Seoul St Marys Hospital, Seoul

Hosp. Univ. Germans Trias I Pujol, Badalona

Hosp Clinic de Barcelona, Barcelona

Inst. Cat. Doncologia-H Duran I Reynals, L'Hospitalet de Llobregat